Callyope R&D
Callyope Medical iPhoneiPadiPod touch
Callyope R&D is a free Medical app for iPhone and iPad by Callyope. Requires iOS 13.0. Updated July 29, 2025.
- Price
- Free
- on the App Store
- Size
- 30 MB
- Age 4+
- Updated
- Jul 29
- 2025 · v0.12.4
Screenshots
About Callyope R&D
Callyope R&D is a data collection application used to train artificial intelligence models aimed at improving the management of psychiatric disorders. This application is designed in collaboration with psychiatrists and patients for disorders such as schizophrenia or bipolarity. Our application uses voice and language analysis techniques to easily enable the development of speech-based clinical trials and clinical information. The data collected will help psychiatrists to adjust treatments and personalize the care they provide. We are committed to improving the quality of life of psychiatric patients. Join us now and be part of the revolution in psychiatric clinical monitoring. Note: For more information on our Callyope company, please visit our website at https://callyope.com/
What’s new
Version 0.12.4 · Updated July 29, 2025
Internal improvements
App privacy
The developer, Callyope, reported these privacy practices to Apple.
Data Not Linked to You
The following data, which may be collected but is not linked to your identity, may be used for the following purposes:
- User Content: Audio Data
Used for: Other Purposes
Alternatives to Callyope R&D
Looking for apps like Callyope R&D? Here are 6 similar apps on the App Store. The highest rated is Canary Speech (4.4/5), and all 6 are free to download.
| App | Rating | Price | Last updated | Compare |
|---|---|---|---|---|
| Callyope R&D | – | Free | July 29, 2025 | |
| Moodeling | – | Free | Jun 18, 2025 | Compare |
| SFORL | – | Free | Sep 18, 2026 | Compare |
| Encéphale 2026 | – | Free | Jan 19, 2026 | Compare |
| ORA PILATES | – | Free | Sep 2, 2026 | Compare |
| EmoDTx | – | Free | Aug 10, 2026 | Compare |
| Canary Speech | 4.4 / 5 (27) | Free | Sep 3, 2026 | Compare |
Compare Callyope R&D with the top alternatives: ratings, updates, ASO score and keyword gaps →